← Back to all substances
N

risperidone

179ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

Class: Atypical Antipsychotic [EPC]

1 INDICATIONS AND USAGE Risperidone tablets are an atypical antipsychotic indicated for: Treatment of schizophrenia ( 1.1 ) As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder ( 1.2 ) Treatment of irrit...

Known as: RISPERIDONE
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
61,170
Total in FDA
93%
Serious Reports
81
Fatal Outcomes

Seriousness

Serious
467
Non-Serious
33

Sex Distribution

Male
256
Female
213
Unknown
31

Age Distribution

0-17
73
18-40
131
41-64
122
65-84
84
85+
16
Unknown
74

Outcomes

Recovered/Resolved
481
Recovering/Resolving
198
Not Recovered/Not Resolved
268
Recovered with Sequelae
59
Fatal
81
Unknown
770

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-87ad90
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...